Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | TSN1611 |
Synonyms | |
Therapy Description |
TSN1611 inhibits active and inactive forms of KRAS G12D, potentially resulting in decreased tumor growth (Cancer Res (2024) 84 (6_Supplement): 3315). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
TSN1611 | TSN-1611|TSN 1611 | KRAS G12D Inhibitor 14 | TSN1611 inhibits active and inactive forms of KRAS G12D, potentially resulting in decreased tumor growth (Cancer Res (2024) 84 (6_Supplement): 3315). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06385925 | Phase Ib/II | TSN1611 | A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation | Recruiting | USA | 0 |